BioWorld

Dec. 11, 2003

Guilford Raising $27.4M; Plans For Aggrastat, Aquavan In Line

GlycoFi's Third Round Brings In $10M For Expansion Plans

Other News To Note

Affymetrix Enters Deal With NuGEN, Prices $100M Notes

It wasn't exactly business as usual Wednesday at Affymetrix Inc., which struck separate financial and product development deals announced hours apart. (BioWorld Today) Read More

Kosan Adds $28M In Stock Sale To Support Early Clinical Work

Today's news in brief

BioWorld

BioWorld briefs for Dec. 10, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 10, 2025.

Epigenetic technology could eliminate misfolded prion proteins

BioWorld Science

The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

Brenig Therapeutics discovers new LRRK2 inhibitors

BioWorld Science

Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...